Binnopharm
http://www.binnopharm.ru
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Binnopharm
Mabwell’s Denosumab Biosimilar Shows Similar Efficacy To Xgeva
Mabwell’s denosumab biosimilar MW032, which awaits approval in China, achieved similar efficacy and safety profiles as the originator Xgeva in oncology patients.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice